Skip to main content
. 2025 May 29;33(6):1301–1321. doi: 10.32604/or.2025.055945

Table 9. List of various drugs, targeting the mitochondrial metabolism in cancer therapy.

Drug Mechanism of action Cancer Reference
Venetoclax and azacytidine Suppression of oxidative phosphorylation induces leukemia stem cell death Acute myeloid leukemia [203,204]
Dichloroacetic acid Inhibits the TCA cycle Liver cancer [205]
Rapamycin Inhibits tumor formation Various cancers [206,207]
MitoTEMPOL Antioxidant (reducing ROS) Various cancers [208]
IACS-010759 inhibits proliferation and induces apoptosis Brain tumor [209]
Gboxin Complex V inhibitor Glioblastoma [210]
Metformin Complex I inhibitor Breast cancer, Colon cancer [211]
Deguelin Complex I inhibitor Melanoma [212]
Rotenone Complex I inhibitor Various cancers [213]
Tigecycline Mitochondria protein translation inhibitor Various cancers [214]
Atovaquone Inhibits mitochondrial complex III Non-small cell lung cancer [215]
Gamitrinib OXPHOS assembly inhibitor Various cancers [216]
Enasidenib IDH2-mutant inhibitor Acute myeloid leukemia [217]

Note: *Adapted from [42,44] and modified.